CVE-2026-118462: Update components download and execute code without proper authenticity verification, relying on
Source GCVE Database
Not known to be exploited · CVSS 9.2 Critical.
Data as of 9 Nov 2026, 13:04 UTC
Thin evidence
One scorer or none| CNA (ENISA) | CVSS 4.0 | 9.2 |
|---|
CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:NExploitation evidence
Disclosed: evidence found.
CVE published 9 Nov 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 9 Nov 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| Infantiacgm.files.delivery | Affected
| Fixed in– |
| Profimcgm.files.delivery | Affected
| Fixed in– |
| Venerecgm.files.delivery | Affected
| Fixed in– |
| Phronesiscgm.files.delivery | Affected
| Fixed in– |
| Infantiacgm.liveupdates | Affected
| Fixed in– |
| Profimcgm.liveupdates | Affected
| Fixed in– |
AI-suggested
Until a fix is available, organizations should exercise caution with update components and consider additional verification measures if possible. Monitor vendor communications for updates on patches or official mitigations.
Description
This vulnerability involves update components that download and execute code without properly verifying its authenticity. The verification process relies on ignored hashes or forgeable checksums, which undermines the integrity checks. Additionally, some update mechanisms allow archive traversal or script execution, increasing the risk of unauthorized code execution.
References
- nvd.nist.gov/vuln/detail/CVE-2026-118462 (opens in a new tab)
- acn.gov.it/portale/w/rilevate-vulnerabilita-in-prodotti-compugroup-medical (opens in a new tab)
- cgm.com/ita_it/magazine/articles/comunicati-stampa/piu-sicurezza-per-farmacie-studi-medici-e-pazienti-cgm-italia-risolve-potenziali-vulnerabilita-software-insieme-a-csirt-italia.html (opens in a new tab)